Xihong Biopharma, a leading regenerative aesthetic manufacturer, is set to present its comprehensive multi-modal regenerative treatment approach to a global audience at the upcoming internationally recognized Aesthetic & Anti-Aging Medicine World Congress (AMWC Southeast Asia 2025), taking place in Bangkok, Thailand, from November 20 to November 22, 2025.
Aesthetic trends worldwide are shifting toward a more natural, individualized look. In response, Xihong Biopharma is proud to offer a comprehensive portfolio of regenerative biomaterials designed to meet these evolving expectations.
Dermal Fillers Designed for Real Results — from delicate facial lines to full-body contouring, our fillers deliver gradual, predictable collagen stimulation for long-lasting, natural-looking volume and improved skin texture.
At AMWC SEA 2025, we’re not just showcasing products — we’re sharing a vision of dual regeneration, where science meets beauty to redefine skin quality and inspire global collaboration.
2025 marks the beginning of our global journey.
We invite distributors, OEM/ODM partners, and local agents worldwide to join us in expanding the reach of next-generation regenerative aesthetic solutions.
Come and meet our team at Booth No. 10 to:
Experience live demonstrations of our latest dermal fillers.
Discuss OEM and distribution partnerships
Access exclusive technical brochures and sampling opportunities
Xihong Biopharma — Restore your natural grace,Lets Shape the Future of Aesthetic Medicine.
About Xihong Biopharma
Established in 2016, we pioneer end-to-end solutions for regenerative medicine medical devices, from R&D to commercial-scale manufacturing.
We are strictly compliant with high production standards to ensure bio-safety and long-term performance.
With China’s first microfluidic regenerative biomaterial production line, our flagship product PLLA Dermal Filler has obtained NMPA Class III certification, while more innovative products are under international approval.
